A Study of RO5185426 in Patients With Metastatic Melanoma
Public ClinicalTrials.gov record NCT01248936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A SINGLE ARM, OPEN LABEL, EXPANDED ACCESS STUDY OF RG7204 IN PREVIOUSLY TREATED PATIENTS WITH METASTATIC MELANOMA
Study identification
- NCT ID
- NCT01248936
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 374 participants
Conditions and interventions
Conditions
Interventions
- RO5185426 Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2010
- Primary completion
- Sep 30, 2011
- Completion
- Sep 30, 2011
- Last update posted
- Aug 11, 2016
2010 – 2011
United States locations
- U.S. sites
- 28
- U.S. states
- 20
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85724-5078 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | San Francisco | California | 94115 | — |
| Not listed | San Francisco | California | 94117 | — |
| Not listed | Santa Monica | California | 90025 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | New Haven | Connecticut | 06520-8063 | — |
| Not listed | Palm Harbor | Florida | 34684 | — |
| Not listed | Tampa | Florida | 33612-9497 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Park Ridge | Illinois | 60068 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Boston | Massachusetts | 02215 | — |
| Not listed | Detroit | Michigan | 48201 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10029 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | New York | New York | 10065 | — |
| Not listed | Cincinnati | Ohio | 45242 | — |
| Not listed | Oklahoma City | Oklahoma | 73104 | — |
| Not listed | Portland | Oregon | 97225 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Columbia | South Carolina | 29210 | — |
| Not listed | Nashville | Tennessee | 37203 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Richmond | Virginia | 23230 | — |
| Not listed | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01248936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2016 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01248936 live on ClinicalTrials.gov.